|
|
|
Volumn 313, Issue 7059, 1996, Pages 756-
|
|
Reasons for stopping drugs are monitored in New Zealand [10]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEZAFIBRATE;
GEMFIBROZIL;
SIMVASTATIN;
DRUG MONITORING;
FOLLOW UP;
HUMAN;
LETTER;
NEW ZEALAND;
PATIENT COMPLIANCE;
PRESCRIPTION;
PRIORITY JOURNAL;
QUESTIONNAIRE;
SIDE EFFECT;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
ANTILIPEMIC AGENTS;
BEZAFIBRATE;
GEMFIBROZIL;
HUMANS;
LOVASTATIN;
NEW ZEALAND;
PRODUCT SURVEILLANCE, POSTMARKETING;
SIMVASTATIN;
|
|
EID: 0029786130
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (3)
|
|
References (0)
|
